Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CARBUR: A National, Multicentre, Non-interventional, Prospective, Longitudinal Study to Assess CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity in Routine Clinical Practice.

NCT06245772 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT06245772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06245772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CARBUR: A National, Multicentre, Non-interventional, Prospective, Longitudinal Study to Assess CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity in Routine Clinical Practice.
Lead sponsor
Ipsen
Phase
Observational
Overall status
Active, not recruiting
Start date
November 16, 2023
Completion date
February 28, 2027
Enrollment
113 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

upper limb injury